Yi-Bin Chen, MD

Articles by Yi-Bin Chen, MD

Challenges in Early Detection of GvHD

ByYi-Bin Chen, MD,Nelson J. Chao, MD, MBA,Hannah Choe, MD,Sophie Paczesny, MD, PhD

January 11th 2022

Hannah Choe, MD; Nelson J. Chao, MD, MBA; and Sophie Paczesny, MD, PhD, comment on the importance of early detection of disease and the role of biomarker testing in GVHD.

Overview of Graft-vs-Host Disease (GVHD)

ByYi-Bin Chen, MD,Nelson J. Chao, MD, MBA,Hannah Choe, MD,Sophie Paczesny, MD, PhD

January 11th 2022

Nelson J. Chao, MD, MBA, and Yi-Bin Chen, MD, define common signs and symptoms of GVHD and share insight on approaching the diagnosis of disease.

Yi-Bin Chen, MD

Articles by Yi-Bin Chen, MD

Challenges in Early Detection of GvHD

Overview of Graft-vs-Host Disease (GVHD)

Trending on OncLive

FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma

PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer

Dr Braunstein on the FDA Approval of Subcutaneous Daratumumab With VRd For Newly Diagnosed Multiple Myeloma

Meta-Analysis Characterizes Nivolumab/Ipilimumab Hyperprogression in Renal Medullary Carcinoma

Ixazomib-Containing Combinations Signal Potential for More PI-Based Regimens in R/R Multiple Myeloma